Literature DB >> 16547239

Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells.

Inés González-García1, Esther Ocaña, Gema Jiménez-Gómez, Antonio Campos-Caro, José A Brieva.   

Abstract

The present study shows that reimmunization with tetanus toxoid (tet) caused a transient increase of the human blood plasma cell (PC) pool, detectable from 6th to 15th day postboost, as well as the temporal alteration of several PC features. Labeling of specific PC with FITC-tet C fragment (tetC) allowed kinetics analysis of the tetC(+) and tetC(-) PC, and revealed remarkable differences between them: 1) the kinetics of tetC(+) PC occurrence was exponential, and most of them appeared in a narrow time frame (5th to 8th day postboost), whereas the tetC(-) PC increase was lower (three to five times) and more prolonged (4th to 15th day postboost). 2) The tetC(+) PC subset contained a fraction of cycling cells, expressed high levels of DR, CD138, and CD126, and responded to IL-6 by improving their survival and Ig secretion; in contrast, the tetC(-) PC showed higher CXCR4 and lower DR and CD138, did not respond to IL-6, and contained a fraction of apoptotic cells. 3) Sequential phenotypic analysis revealed maturational changes within the tetC(+), but not tetC(-), PC subset; sequencing of tetC(+) PC IgVH genes showed clear features of Ag selection. 4) The tetC(+) PC expressed several times more positive regulatory domain I- binding factor 1/B lymphocyte-induced maturation protein 1 transcription factor than the tetC(-) PC. 5) The tetC(-) PC and bone marrow resident PC similarly expressed low DR and high CXCR4, but differed in that the latter exhibited higher levels of CD31, CD138, and positive regulatory domain I- binding factor 1/B lymphocyte-induced maturation protein 1. These findings support the view that tetC(+) PC contain bone marrow PC precursors, and tetC(-) PC probably belong to a removable compartment of aged PC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547239     DOI: 10.4049/jimmunol.176.7.4042

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

3.  Identification of human plasma cells with a lamprey monoclonal antibody.

Authors:  Cuiling Yu; Yanling Liu; Justin Tze Ho Chan; Jiefei Tong; Zhihua Li; Mengyao Shi; Dariush Davani; Marion Parsons; Srijit Khan; Wei Zhan; Shuya Kyu; Eyal Grunebaum; Paolo Campisi; Evan J Propst; David L Jaye; Suzanne Trudel; Michael F Moran; Mario Ostrowski; Brantley R Herrin; F Eun-Hyung Lee; Ignacio Sanz; Max D Cooper; Götz Ra Ehrhardt
Journal:  JCI Insight       Date:  2016-03-17

4.  Differential transcriptome and development of human peripheral plasma cell subsets.

Authors:  Swetha Garimalla; Doan C Nguyen; Jessica L Halliley; Christopher Tipton; Alexander F Rosenberg; Christopher F Fucile; Celia L Saney; Shuya Kyu; Denise Kaminski; Yu Qian; Richard H Scheuermann; Greg Gibson; Iñaki Sanz; F Eun-Hyung Lee
Journal:  JCI Insight       Date:  2019-05-02

5.  Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus.

Authors:  Denise A Kaminski; Chungwen Wei; Alexander F Rosenberg; F Eun-Hung Lee; Ignacio Sanz
Journal:  Methods Mol Biol       Date:  2012

6.  Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.

Authors:  Eduardo L V Silveira; Sudhir P Kasturi; Yevgeniy Kovalenkov; Ata Ur Rasheed; Patryce Yeiser; Zarpheen S Jinnah; Traci H Legere; Bali Pulendran; Francois Villinger; Jens Wrammert
Journal:  J Immunol Methods       Date:  2014-11-08       Impact factor: 2.303

7.  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Authors:  Jessica L Halliley; Christopher M Tipton; Jane Liesveld; Alexander F Rosenberg; Jaime Darce; Ivan V Gregoretti; Lana Popova; Denise Kaminiski; Christopher F Fucile; Igor Albizua; Shuya Kyu; Kuang-Yueh Chiang; Kyle T Bradley; Richard Burack; Mark Slifka; Erika Hammarlund; Hao Wu; Liping Zhao; Edward E Walsh; Ann R Falsey; Troy D Randall; Wan Cheung Cheung; Iñaki Sanz; F Eun-Hyung Lee
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

8.  Age-related differences in human palatine tonsillar B cell subsets and immunoglobulin isotypes.

Authors:  Jino Lee; Dong-Yeop Chang; Sang-Wook Kim; Yoon Seok Choi; Sea-Yuong Jeon; Vito Racanelli; Dae Woo Kim; Eui-Cheol Shin
Journal:  Clin Exp Med       Date:  2015-01-25       Impact factor: 3.984

9.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

10.  Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Authors:  Clarisa M Buckner; Susan Moir; Jason Ho; Wei Wang; Jacqueline G Posada; Lela Kardava; Emily K Funk; Amy K Nelson; Yuxing Li; Tae-Wook Chun; Anthony S Fauci
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.